Nootropic
Adamax
SaveA synthetic noopept analog featuring an adamantane moiety, reportedly designed to enhance oral bioavailability and duration relative to noopept.
Quick verdict
Extremely limited data even by research-chemical standards. Most information is anecdotal from self-experimenters.
Evidence score
A rough internal score reflecting quantity, quality, and consistency of human evidence. Not a clinical recommendation.
What the research shows
No peer-reviewed human or animal studies are readily available. Claims derive from vendor descriptions and user self-reports.
Benefits
- Anecdotal reports of improved verbal fluency
- Claimed longer duration of action than noopept
Dosage notes
No validated dosing exists. Anecdotal reports use 10–20 mg sublingually.
Side effects
- Unknown — no safety data available
Who should be cautious
Completely uncharacterized safety profile. Not approved for human use anywhere.
What this page cannot tell you
Without published research, any claimed mechanism or benefit is speculative.
Leaderboard scores
- Memory20
- Focus20
Write a review
Sign in to write a review.